After hours: February 3 at 6:26:57 PM EST ...

In this article, we are going to take a look at where Agree Realty Corporation (NYSE:ADC) stands against the other monthly dividend stocks. Despite common perceptions, 2024 turned out to be a ...

The FDA thinks an antibody-drug conjugate (ADC) developed by AbbVie could set new standards in treatment for certain patients with lung cancer, awarding the drug breakthrough status. Teliso-V ...

School of Chemistry and Chemical Engineering, Shanghai Jiao Tong University, 800 Dongchuan Road, Shanghai 200240, People’s Republic of China ...

Drug-resistant infections occur when pathogens change in ways that render antimicrobial drugs ineffective. As a result, the pathogens survive and continue to spread. When infections are treatable with ...

Background The periprocedural management of antithrombotic medications in patients with chronic subdural hematoma (cSDH) after middle meningeal artery embolization (MMAE) or surgical evacuation is ...

or MMAE cytotoxin payload. Nectin-4 is a validated target because in December 2023, the FDA approved enfortumab vedotin (PADCEV), a Nectin-4 targeting antibody drug conjugate molecule developed by ...

Drug addiction is a condition in which there is uncontrolled use of a substance with a harmful outcome. Drugs overstimulate the brain’s reward circuit, producing pleasure or euphoria. With repeated ...

The first ever approval of an antibody-drug conjugate (ADC) did not prove to be a success. The treatment, known by brand name Mylotarg (gemtuzumab ozogamicin), was given marketing authorisation by ...

The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed ...

Oxide nanoparticles, particularly iron oxide, ceria and silica nanoparticles, hold significant promise for biomedical applications owing to their unique magnetic, catalytic and porous properties ...

Drug development describes the process of developing a new drug that effectively targets a specific weakness in a cell. This process involves specific pre-clinical development and testing ...